(Q45270989)

11 December 2017

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters (English)

1 reference

11 December 2017

3

B Kos-Kudla

1 reference

11 December 2017

L Sieminska

1

1 reference

11 December 2017

B Marek

2

1 reference

11 December 2017

D Niedziolka

4

1 reference

11 December 2017

D Kajdaniuk

5

1 reference

11 December 2017

M Nowak

6

1 reference

11 December 2017

J Glogowska-Szelag

7

1 reference

11 December 2017

1 June 2004

1 reference

Journal of Endocrinological Investigation

11 December 2017

1 reference

11 December 2017

27

1 reference

11 December 2017

6

1 reference

11 December 2017

528-534

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03347474

11 December 2017

0 references

cites work

Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Prediction of insulin sensitivity in nonobese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Sex hormone levels and risk of cardiovascular events in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Serum sex hormone levels in postmenopausal women with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347474

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

21 January 2018

1 reference

12 December 2020

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

12 December 2020

Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.

1 reference

12 December 2020

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

1 reference

12 December 2020

Decreased plasma adiponectin concentration in patients with essential hypertension

1 reference

12 December 2020

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

12 December 2020

Adiponectin levels in women with polycystic ovary syndrome

1 reference

12 December 2020

Cardiovascular aspects of androgens in women

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347474

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference